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Background: Cardiac disease in dogs impacts the quality of life (QoL) of their owners,
but owners' QoL has not been comprehensively assessed in this population.
Objectives: To develop, validate, and provide preliminary data from a health-related
QoL (hrQoL) questionnaire for owners of dogs with cardiac disease.
Subjects: A total of 141 owners of dogs with cardiac disease were studied.
Methods: An owner hrQoL (O-hrQoL) questionnaire containing 20 items related to areas
of a person's life that could be impacted by caring for a dog with cardiac disease was
developed and administered to owners of dogs with cardiac disease. The highest possible
total score was 100, with higher scores indicating a worse hrQoL. Readability, internal
consistency, face and construct validity, and item-total correlations were assessed.
Results: Median O-hrQoL score was 35 (range, 0-87). The questionnaire had good
internal consistency (Cronbach's α = 0.933), construct validity (Spearman's
r = 0.38-0.53; Kendall's τ = 0.30-0.43; P < .001), and item-total correlation
(Spearman's r = 0.44-0.79; Kendall's τ = 0.34-0.66; all P < .001). Fifty percent of
owners indicated a negative effect of dogs' cardiac disease on their own QoL, but all
owners responded that caring for their dogs either had strengthened (n = 76; 53.9%)
or had no effect on their relationship with their dog (n = 65; 46.1%).
Conclusions and clinical importance: The O-hrQoL questionnaire had good validity,
and results suggest that owners' QoL is significantly impacted by caring for dogs with
cardiac disease. Additional research on effective approaches to minimizing the nega-
tive effects of a dog's cardiac disease on the owner is warranted.
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1 | INTRODUCTION
Health-related quality of life (hrQoL) instruments can provide useful
information for veterinarians about an animal's clinical signs and effi-
cacy of treatment, as well as serving as an endpoint for clinical trials.
While there are a number of generic hrQoL instruments validated for
Abbreviations: ACVIM, American College of Veterinary Internal Medicine; DCM, dilated
cardiomyopathy; DMVD, degenerative mitral valve disease; hrQoL, health-related quality of
life; O-hrQoL, owner health-related quality of life; QoL, quality of life.
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dogs,1-6 cardiac disease has some specific clinical signs and medica-
tion-related issues. Therefore, cardiac-specific hrQoL instruments that
provide a quantitative assessment of owners' perception of their pets'
QoL have been developed.7-9
Assessment of the owners' hrQoL also might provide important
information that can impact pets' care. Studies in people have
shown that heart failure is associated with a high burden on the
caregiver.10-12 Therefore, assessment of caregiver hrQoL can help
to quantify an individual caregiver's burden and identify resources
to address challenges and concerns that affect both the caregiver
and the pets with cardiac disease. Two instruments have been vali-
dated for the assessment of hrQoL for the caregivers of human
heart failure patients.13,14 Improving caregiver hrQoL can improve
human patients' hrQoL and outcomes.10-12 This might be even
more important in veterinary medicine given the option for eutha-
nasia, where cost of care, prognosis given to the owner by the cli-
nician, and QoL are all important factors in the decision-making
process.15,16
There are 3 recent studies of hrQoL or burden among dogs' care-
givers: an instrument for caregivers of dogs with cancer,17 an instru-
ment for caregivers of dogs with a variety of chronic or terminal
diseases,18 and an abbreviated instrument for caregivers of dogs and
cats with a variety of illnesses.19 The results of these studies demon-
strated a negative association between the diseases or symptoms and
the caregivers' hrQoL, stress, anxiety, depression, and psychosocial
function.17-19 These are all valuable instruments that provide impor-
tant information on caregiver burden. However, all were developed
and validated in dogs with cancer17 or in dogs and cats with a variety
of medical conditions.18,19 Cardiac disease has a number of disease-
specific signs and medications that can potentially impact the owner
hrQoL, so a disease-specific owner hrQoL questionnaire might pro-
vide complementary information to the general caregiver burden
assessments, as they have for caregivers of human patients with heart
failure.13,14
A short, 7-item, cardiac-specific hrQoL questionnaire assessing
the impact of dogs' cardiac disease on their owners was shown to
have good reliability and validity.20 Owners' hrQoL scores were sig-
nificantly correlated with the dogs' hrQoL scores7 and with disease
severity.20 However, during data analysis and further discussions
with dog owners, a number of issues that could potentially impact
owner hrQoL were identified as missing from the short question-
naire, such as guilt, sadness, physical tiredness, and worry about the
dog's dyspnea. Another limitation of the previous study20 was that
owner demographics were not collected so their role could not be
evaluated. In addition, construct validity could not be assessed because
an independent question on owner-reported hrQoL was not included.
Finally, the data for that study were collected before the launch of
pimobendan and owner hrQoL could be different with widespread use
of this medication. Therefore, the objective of our study was to
develop an owner hrQoL instrument for owners of dogs with cardiac
disease; assess its readability, internal consistency, face and construct
validity, and item-total correlations; and provide preliminary data from
owners of dogs with cardiac disease.
2 | MATERIALS AND METHODS
The study was reviewed by the university's Institutional Review Board
and designated exempt (IRB # 1710037). Therefore, owners did not
sign an informed consent form but were informed that participation
was voluntary and that answers were confidential.
2.1 | Participants
Owners of all dogs with degenerative mitral valve disease (DMVD) or
dilated cardiomyopathy (DCM) visiting the cardiology services at
either of the university's 2 veterinary hospitals (1 veterinary teaching
hospital and 1 specialty practice) with cardiology services between
28 December 2017 and 12 October 2018 were eligible for the study.
Owners were invited by a veterinarian, veterinary technician, or veter-
inary student to complete the questionnaire while in the waiting area
before an appointment with the cardiology service or while waiting
for the echocardiogram to be completed. Owners were not compen-
sated for their participation.
The severity of each dog's heart disease at the time of question-
naire completion was categorized using the American College of Veteri-
nary Internal Medicine (ACVIM) classification.21 The number of cardiac
medications being administered to each dog was also recorded.
2.2 | Measures
2.2.1 | Owners' health-related quality of life
Based on a review of the human and veterinary literature, interviews
with owners of dogs with cardiac disease, and the authors' clinical
experience, a list of items related to areas of a person's life that could
be impacted by caring for a dog with cardiac disease was generated.
These included items on the effect of the dog's illness on the owner's
life, including social life, burden of cost of care, worry, and sleep dis-
ruption. From this information, 25 items were identified to assess an
owner's perception of the degree to which the dog's cardiac disease
affected the owner's lifestyle during the preceding 30 days (eg, by
affecting their work schedule or by causing problems because of
excessive urination; Appendix). For each item, the owner was asked
to rate how much a given part of his or her life was affected by the
dog's condition on a scale of 0-5, where 0 = not at all and 5 = very
much. Responses were summed to obtain an overall score, with a pos-
sible range of 0 to 125, with higher scores indicating a worse owner
hrQoL.
Face validity, the degree to which the questionnaire, on its face,
seemed to reflect what it was designed to measure, was established
before starting data collection by reviewing the questionnaire with
veterinary colleagues and with owners of dogs with cardiac disease
and incorporating their comments into a final version of the instru-
ment. The readability of the O-hrQoL questionnaire was determined
using the Flesch-Kincaid method, an algorithm available in Microsoft
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Word (Word 2000, Microsoft Corp, Bellevue, Washington), that is
designed to estimate the grade level needed to comprehend written
text. The O-hrQoL questionnaire was assessed to be written at a level
of 6.3, meaning that owners with a 6th-grade reading level or higher
should be able to comprehend the questionnaire and that it would be
easy to read by 75% of readers at that level.
2.2.2 | Owner QoL
To assess how the hrQoL assessment did or did not differ from the
owners' overall QoL, 2 additional questions were included about the
owners' overall QoL: “How would you rate your overall quality of
life?” And “What impact has your dog's heart disease had on your
quality of life?”
2.2.3 | Distress
To determine whether owners’ hrQoL differed from other measures
of well-being, 1 question about general distress was asked: “How
often do your worries about caring for your dog overwhelm you?”
2.2.4 | Additional questions
While not part of the validation of the O-hrQoL instrument, owners
were also asked, “How has caring for your dog's heart disease chan-
ged your relationship with him or her?” Finally, a space for additional
comments was also provided.
2.3 | Analysis
Item reduction was performed to identify the underlying components
characterizing O-hrQoL using the most efficient subset of items as
possible. From the initial 25-item instrument, item reduction was per-
formed by conducting principal components analysis with varimax
rotation. Items with factor loadings >0.5 within a single factor were
considered related and combined into a subscale. Cronbach's α reli-
ability was computed for each subscale. After computing an initial
Cronbach's α for each subscale, items were assessed to determine the
effect of deleting items from the subscale to improve efficiency. An
item was deleted if doing so did not drop the overall Cronbach's α for
the subscale below 0.90. Clinical perspective was combined with a
review of each item's performance in the above analyses. An abbrevi-
ated 20-item instrument was generated (O-hrQoL questionnaire),
which was used for all subsequent analyses.
Internal consistency of the O-hrQoL questionnaire was assessed
by calculating Cronbach's α. Internal consistency was considered excel-
lent when Cronbach's α ≥0.90, good when Cronbach's α was ≥0.80,
and acceptable when Cronbach's α was ≥0.70. Owners' hrQoL scores
were compared between owner sex and dog disease groups with
Mann-Whitney U tests, while scores were compared among multiple
groups (eg, owner age groups) using Kruskal-Wallis tests. Owners'
hrQoL scores were compared with the number of cardiac medications
being administered to the dog using Spearman's rank correlation and
Kendall's τ analysis. Construct validity, measured with 3 different vari-
ables (ie, total O-hrQoL score versus the 2 overall owner QoL ques-
tions and total O-hrQoL score versus ACVIM classification), was
assessed using Spearman's rank correlation and Kendall's τ analysis,
with the hypothesis that the total O-hrQoL score would be signifi-
cantly positively correlated with both overall O-QoL questions and
with ACVIM classification. Item-total correlation was assessed using
Spearman's rank correlation analyses to determine if any individual
items had limited correlation with the total owner hrQoL score.
Cohen's d effect size was interpreted as small (≥0.2), medium (≥0.5), or
large (≥0.8). All quantitative analyses were performed using commercial
statistical software (Systat 13, Systat, Inc., San Jose, California, and
SPSS 24.0, IBM Corp., Armonk, New York), with P< .05 considered sta-
tistically significant. Finally, qualitative data from additional comments
provided by owners were categorized according to similar themes.
3 | RESULTS
The O-hrQoL questionnaire was administered to 141 owners of dogs
with cardiac disease: 83 at hospital 1 and 58 at hospital 2. There were
no significant differences in the results between the 2 hospitals, so
data were combined for all subsequent analyses. The population
included 85 male dogs (74 castrated) and 56 female dogs (53 spayed).
Mean age of the dogs was 11.0 ± 3.0 years, and underlying diseases
included DMVD (n = 121) and DCM (n = 20). The ACVIM classifica-
tions included B1 (n = 6), B2 (n = 52), C (n = 71), and D (n = 12). The
time since diagnosis of heart disease ranged from 8 to 2632 days
(median = 450 days). The median number of cardiac medications
being administered was 3 (range, 0-8). Owner age categories included
18 to 30 years (n = 3), 31 to 45 years (n = 36), 46 to 60 years (n = 52),
and >60 years (n = 47), with 3 owners declining to respond to this
question. One hundred fourteen owners were female, 25 were male,
and 2 declined to respond to this question.
The initial 25-item instrument was reduced to a 20-item abbreviated
instrument through principal components analysis. The 5 items that were
removed are listed in Table 1. All further analyses are for the final
20-item instrument (O-hrQoL questionnaire; Appendix). Cronbach's
α, which measures internal consistency, for the 20-item O-hrQoL ques-
tionnaire was 0.933, indicating excellent internal consistency. The median
total O-hrQoL score was 35 (range, 0-87, with a total possible score of
100, where higher scores represented worse O-hrQoL). Median overall
QoL of the owner was 2 (range, 1-5, with 5 indicating worse QoL). For
the impact of the dogs' cardiac disease on the owners' overall QoL,
11 owners (7.8%) responded that the dogs' cardiac disease had a positive
effect on the owners' QoL, 58 (41.1%) owners indicated no effect, and
70 (49.7%) owners indicated a negative effect (with 2 owners not
responding to this item). Owner hrQoL score was not significantly differ-
ent among owners of different age groups (18-30 years: median = 49
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[range, 21-64]; 31-45 years: median = 43 [range, 3-87]; 46-60 years:
median = 36 [range, 1-76]; >60 years: 29 [range, 0-65]; P = .13; effect
size = 0.27), different sexes (female: median = 35 [range, 0-87]; male:
median = 37 [range, 6-78]; P = .65; effect size = 0.08), or between dogs
with DCM versus DMVD (DMVD: median = 33 [range, 0-87]; DCM:
median = 40 [range, 3-75]; P = .38; effect size = 0.15). Owner hrQoL
score was significantly (positively) associated with the number of cardiac
medications (Spearman's r = 0.57; Kendall's τ = 0.43, both P < .001). Ana-
lyses of construct validity indicated a positive correlation between O-
hrQoL score and general QoL question 1 (How would you rate your over-
all quality of life? Spearman's r = 0.38; Kendall's τ = 0.30, both P < .001)
and between the O-hrQoL score and general QoL question 2 (What
impact has your dog's heart disease had on your quality of life? Spe-
arman's r = 0.51; Kendall's τ = 40, both P < .001). There also was a
significant positive correlation between O-hrQoL score and ACVIM clas-
sification (Spearman's r = 0.53; Kendall's τ = 43, both P < .001). Each indi-
vidual item in the item-total correlation, in which individual items were
compared with the total O-hrQoL score, was significant (all P < .001),
but the r value was lowest for the item about difficulty giving medications
(Spearman's r = 0.44; Kendall's τ = 0.34) and highest for the items on
making the owner feel physically tired (Spearman's r = 0.79) and making
the owner feel overwhelmed (Spearman's r = 0.79; Kendall's τ = 0.66;
Table 1).
The total O-hrQoL score also was significantly correlated with
the item on general distress (Spearman's r = 0.64; Kendall's τ = 0.51,
both P < .001). The median score for the item on how often worries
about caring for their dog overwhelmed them was 2 (range, 1-5 with
higher scores indicating more worries), with 46 owners (32.9%)
TABLE 1 Item-total correlation comparing individual items from the 20-item owners' health-related quality of life (O-hrQoL) questionnaire
for owners of dogs with heart disease to the total O-hrQoL score
Item Spearman's r Kendall's τ P value
How much did your dog's heart disease negatively affect your quality of life
during the last 30 days by:
1. Disrupting your sleep habits (eg, because your dog is restless, coughing,
or needs to go out)
0.62 0.49 <.001
2. Making you reluctant to leave home for social activities or vacations 0.72 0.56 <.001
3. Causing problems due to your dog's increased urination, such as having
accidents in your home
0.53 0.43 <.001
4. Causing you to change your plans or avoid making plans 0.71 0.55 <.001
5. Affecting your work schedule 0.69 0.56 <.001
6. Making it hard to give medicines to your dog 0.44 0.34 <.001
7. Making it hard to give medicines at the recommended times or keeping track of medicines 0.53 0.42 <.001
8. Creating high costs for medical care 0.57 0.45 <.001
9. Having to make decisions about when to give more or less of a medicine
(such as furosemide) depending on your dog's breathing
0.58 0.46 <.001
10. Making you feel overwhelmed 0.79 0.66 <.001
11. Making you feel stressed 0.74 0.60 <.001
12. Making you feel physically tired 0.79 0.65 <.001
13. Making you feel sad 0.77 0.61 <.001
14. Making you feel guilty that you cannot do enough to manage your dog's heart disease 0.75 0.60 <.001
15. Making you worry whether your dog is having difficulty breathing 0.77 0.61 <.001
16. Making you anxious about what your dog will experience with
recommended testing and recheck exams
0.61 0.46 <.001
17. Making you worry that your dog cannot or should not exercise 0.69 0.54 <.001
18. Making you concerned that you cannot or should not feed foods that your dog enjoys 0.60 0.48 <.001
19. Making you worry that your dog could die suddenly 0.66 0.52 <.001
20. Making you worry that you will have to decide on the right time to put your dog to sleep 0.71 0.56 <.001
Items that were removed after principal components analysis were:
• Affecting the amount of time you spend on the TV or computer 0.51 0.41 <.001
• Affecting the foods that you eat 0.46 0.37 <.001
• Having to make decisions about the best diet for your dog 0.53 0.40 <.001
• Making you worry about your dog's overall condition 0.74 0.58 <.001
• Making you worry that your dog might be in pain 0.76 0.61 <.001
1122 FREEMAN ET AL.
responding that their worries overwhelmed them sometimes and
20 owners (14.2%) responding that their worries overwhelmed them
often or always. Examples of additional open-ended comments pro-
vided by participants about how the dogs' condition impacted the
owners' lives included: “A low stress level that never goes away,”
“Lack of sleep, exercise, and eating. All I do is research how to fix his
disease and pray it will reverse,” and “The hardest long-term thing I
have ever done. I would not wish this on anyone.” Nonetheless,
owners responded that caring for their dogs' heart disease had either
strengthened their relationship with the dog (n = 76; 53.9%) or had no
effect on the relationship (n = 65; 46.1%). In fact, the most common
additional comments were about how their dogs' heart disease made
them love/appreciate them more (“Every day she has with us is a gift”
and “Makes me enjoy/appreciate time with him more”). The second
most common theme of the additional comments was concerns about
the dog's death or unknown future for the dog (eg, “I fear for the
inevitable,” “The one thing that worries me is losing him,” and “The
worst part is the unknown.”)
4 | DISCUSSION
The results of this study demonstrated that this O-hrQoL question-
naire had good face and construct validity, readability, and internal
consistency. Most comments from the open-ended questions served
to reinforce the importance and impact of the various items on the O-
hrQoL. In addition, all individual items in the final 20-item instrument
were significantly associated with the total O-hrQoL score, although
the correlation coefficients ranged from 0.44 to 0.79. However, even
for the item with the lowest correlation coefficient (ie, difficulty giving
medications [r = 0.44]), some owners gave a high score, indicating a
large effect of this issue on their QoL. Therefore, it appeared that all
20 items in the final instrument were useful to include in the ques-
tionnaire. After gathering additional feedback from caregivers, we
propose revised wording for the item on difficulty giving medications
(question 6; Appendix) so that it is clearer that this item refers to the
physical act of administering a medication.
From the preliminary testing in dogs with cardiac disease, there
was a wide range in the total O-hrQoL scores (0-87). The total O-
hrQoL score was significantly associated with severity of disease and
number of cardiac medications, but not with age or sex of the owner
or with the dogs' underlying disease. In people, caregiver physical and
mental health can be affected by both caregiver factors, such as age,
social support, and income, as well as patient factors, such as severity
of disease, symptom burden, and mental health.22-24 Results from
1 study in cats with cardiac disease showed that many owners had
moderate to extreme difficulty giving medications to their cats and
that many perceived administering medications had a negative effect
on their cats' QoL.25 The wide range of O-hrQoL scores in our study
also emphasizes the fact that some owners will be markedly affected
by the care of their dogs with cardiac disease. Assessing the impact
that the dogs' cardiac disease is having on the owners' QoL might be
important to address areas of difficulty or distress (eg, disruption of
sleep habits, difficulty giving medications, dietary decisions/restric-
tions, and cost). Providing individual or group support facilitated by a
mental health professional, such as a licensed social worker, psycholo-
gist, or professional counselor might help to address the high care-
giver burden found in some owners.
When asked how the dogs' cardiac disease affected their own
QoL, many of the owners (50%) responded that cardiac disease nega-
tively affected their own QoL and additional comments provided by
the owners often reflected this (eg, “My quality of life is based on my
dog's quality of life.”) However, none of the participants said that car-
ing for the dogs weakened their relationship. In fact, 54% said it
strengthened relationship (and 46% said no effect). This information
might be useful to address in future studies or to better prepare
owners regarding the care of dogs with cardiac disease.
While the median score for distress was only 2 (ie, worries about
caring for their dogs rarely overwhelms them), approximately 50% of
owners reported that their worries about caring for their dogs over-
whelmed them sometimes, often, or always (with 14% responding
that their worries overwhelmed them often or always). These results
suggest that this is something clinicians should consider when com-
municating with owners. If owners are having a high degree of dis-
tress because of caring for their dogs with cardiac disease, providing
information that might reduce the level of distress or referring the
owner to a mental health professional might be helpful.
The current O-hrQoL questionnaire included 2 items that addressed
the dogs' death (ie, “making you worry that your dog could die suddenly”
and “making you worry that you will have to decide on the right time to
put your dog to sleep”), but additional comments provided by partici-
pants commonly addressed their dogs' death or unknown future (eg, “I
fear for the inevitable,” “The one thing that worries me is losing him,” and
“The worst part is the unknown”). Although these are only preliminary
data, this suggests owners of dogs with cardiac disease might benefit
from more patient-centered discussions about end-of-life care. Studies in
human heart failure patients have shown that key intervention priorities
include not only education on disease specifics, but also recommenda-
tions to help enhance QoL and cope with heart failure, and discussions
of future outlook and care decisions.12,26 Studies of veterinarians using
undisclosed standardized clients to assess patient-centered communica-
tion during discussions about euthanasia showed that veterinarians fre-
quently discussed the patient's disease, but there was “lack of
exploration of client feelings, ideas, expectations, and the effect of the
illness on the animal's function” (even though the veterinarians thought
they addressed these components).27,28
There are a number of limitations of the current study that are
important to address. One of the major limitations was that validated
instruments were not used as part of the determination of construct
validity (ie, the 2 questions on overall owner QoL) or for the additional
question on owner distress. Using validated instruments were consid-
ered during design of the study but the long length of the instruments
and the additional time they would take for owners to complete was of
concern. Therefore, we elected to keep the instrument and number of
items as short as possible. Additional construct validation against full-
length, validated instruments would be useful. Participants were limited
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to owners of dogs with DVMD or DCM. This could limit the generaliz-
ability of the instrument. However, since these are the 2 most common
canine cardiac diseases, it should be applicable to most dogs with car-
diac disease. Further research is needed to determine whether the
instrument is also applicable for caregivers of dogs with other forms of
cardiac disease. This instrument also was developed specifically for
dogs. Given some differences found in previous studies of hrQoL in
dogs versus cats,7,8 we believe that having separate instruments for the
2 species is important. Studies to evaluate the effect of feline cardiac
disease on owner hrQoL are warranted. Another limitation is that only
2 hospitals in 1 geographic region were included although they repre-
sented 1 teaching hospital and 1 referral practice. Additional research in
other types of veterinary hospitals and other regions would help to
ensure the results are generalizable to other regions. The study popula-
tion only included owners who came to a specialty hospital and
excluded owners of dogs that had already died. Including these other
populations may have provided different results. Similarly, very few
owners were in the 18 to 30 year age group and a large proportion of
them were female, so further validation studies that include younger
age groups and with men would be useful. Some additional adjustment
of wording of the items may be beneficial. For example, it is unclear
whether the wording of some of the items could have led the respon-
dents toward a more negative response. We did not evaluate test-
retest reliability in our study so this would be important to do in future
studies. The current results provide preliminary data on the QoL for
owners of dogs with cardiac disease, but further research is needed.
Finally, no questions about the relationship between the dog and the
owner were included. Assessment of how long the pet was owned and
degree of attachment (eg, Companion Animal Bonding Scale)29 could
provide valuable information to help advance research on hr-QoL and
caregiver burden in owners of dogs with cardiac disease. Although
much additional research is needed to better understand these issues,
hrQoL questionnaires for both dogs and owners might help to identify
areas for discussion regarding medications, diet, home care, costs, and
end-of-life care to optimize the care of dogs with cardiac disease.
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APPENDIX A
The following questions refer to the effects that your dog's heart disease has had on your quality of life in the last 30 days. If you believe a ques-
tion does not apply to you or it is not related to your dog's heart disease, then circle 0 (Not at all) and go on to the next item. If the question does
apply to you, then circle the number rating how much it has impacted your life. If there is any question that you are uncomfortable answering, just
leave it blank (this will not affect your dog's care in any way).
How much did your dog's heart disease negatively affect your quality of life during the last 30 days by (please circle one answer for each
question):
General questions (please circle one answer for each question).







Not at all Very little
Very
much
1. Disrupting your sleep habits (for example, because your dog is restless, coughing, or needs to go out). 0 1 2 3 4 5
2. Making you reluctant to leave home for social activities or vacations. 0 1 2 3 4 5
3. Causing problems due to your dog's increased urination, such as having accidents in your home. 0 1 2 3 4 5
4. Causing you to change your plans or avoid making plans. 0 1 2 3 4 5
5. Affecting your work schedule. 0 1 2 3 4 5
6. Making it hard to give medicines to your dog.
Proposed revised wording: making it hard to get your dog to take medicines
0 1 2 3 4 5
7. Making it hard to give medicines at the recommended times or keeping track of medicines. 0 1 2 3 4 5
8. Creating high costs for medical care. 0 1 2 3 4 5
9. Having to make decisions about when to give more or less of a medicine (such as furosemide) depending
on your dog's breathing.
0 1 2 3 4 5
10. Making you feel overwhelmed. 0 1 2 3 4 5
11. Making you feel stressed. 0 1 2 3 4 5
12. Making you feel physically tired. 0 1 2 3 4 5
13. Making you feel sad. 0 1 2 3 4 5
14. Making you feel guilty that you cannot do enough to manage your dog's heart disease. 0 1 2 3 4 5
15. Making you worry whether your dog is having difficulty breathing. 0 1 2 3 4 5
16. Making you anxious about what your dog will experience with recommended testing and recheck
exams.
0 1 2 3 4 5
17. Making you worry that your dog cannot or should not exercise. 0 1 2 3 4 5
18. Making you concerned that you cannot or should not feed foods that your dog enjoys. 0 1 2 3 4 5
19. Making you worry that your dog could die suddenly. 0 1 2 3 4 5
20. Making you worry that you will have to decide on the right time to put your dog to sleep. 0 1 2 3 4 5










2. What impact has your dog's heart disease







3. How has caring for your dog's heart disease changed
your relationship with him or her?




It's weakened our relationship
3
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